Associate Professor Georgina Long has won the InStyle Women In Style Award
14 May 2015
Associate Professor Georgina Long of Melanoma Institute Australia (MIA) has won the InStyle Women In Style Awards for the Science and Environment category. Dr Long was nominated by InStyle over 6 months ago and since then there has been a public voting campaign as well as selection by a very high-powered influential panel of women including Jana Wendt, Collette Dinnigan, Nicola Kidman, Deborah Lee Furness and Layne Beachley.
Other nominees for the Science & Environment category were Kirsty Albion and Lucy Manne (Co-Directors Australian Youth Climate Coalition) and Mara Bún (Founder of Green Cross Australia).
Dr Long is a principal investigator in clinical trials of drugs given to patients with early stage melanoma as well as patients with stage four melanoma at MIA. It is through work like this that a “penicillin moment” is emerging in the field of cancer.
“For the first time we are showing that you can harness the immune system to kill cancer cells,” Dr Long explains.
Dr Long was presented with the award at the InStyle event on Wednesday night.
“I know that life is short, I see that in my work, I want to make the most of every day,” said Dr Long in her acceptance speech.
One person still dies from melanoma every 6 hours in Australia and at MIA we are working hard to change this devastating statistic. With your support we can continue to find melanoma breakthroughs that result in life changing results for melanoma patients.
Help us reach our ultimate goal of finding a cure. Donate now.
Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA) have announced a new multi-year agreement to provide enhanced support services for melanoma patients nationally.
It is time again to say thank you to our incredible community fundraisers who are helping us get closer to our goal of zero deaths from melanoma.
MIA has presented promising data regarding progression-free survival rates for advanced melanoma patients at the ESMO 2019 Congress in Barcelona.
Another month has flown by and yet again we have a host of amazing community fundraisers who generously gave up their time to help us reach our goal of zero deaths from melanoma.
Comments in favour of giving patients with BRAF-positive melanoma access to first-line immunotherapy need to be submitted online prior to October 9, 2019.
Jay's Longest Melanoma March documentary is screening this Sunday 22 September at 1pm (AEST) on Channel 10, capturing behind the scenes of the 2000km walk, Adelaide to Sydney in 50 days. Uniting to end melanoma.
It’s been a month since we highlighted some of our incredibly generous community fundraisers. We thought we’d have a look back at August and put the spotlight on more of the wonderful people who give up their time to fundraise for MIA, so we can continue to edge closer to our goal of zero deaths from melanoma.
They are a formidable team - in work and in play
This week, Melanoma Institute Australia hosted the first of six
Federal government urged
We want to thank every member of Team Melanoma and everyone who donated to them. With your help, we are moving closer to our goal of zero deaths from melanoma!
Lauren O'Brien tells us why she's running for a cause close to her heart
MIA could not do what we do without the incredible support and effort of our community fundraisers. We’d like to highlight some of the wonderful events organised by our community in
An international study, led by researchers from Melanoma Institute Australia, QIMR Berghofer Medical Research Institute and The University of Sydney as part of the Australian Melanoma Genome Project, has discovered that a drug traditionally used to treat a
Researchers from Melanoma Institute Australia took centre stage at the American Society of Clinical Oncology Annual Meeting in Chicago. Results presented by MIA’s contingent have the potential to create better patient outcomes and change the way advanced melanoma
Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.
“I’m the age Emma was when she passed away. It almost feels
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions